Cargando…
Implication of chemo‐resistant memory T cells for immune surveillance in patients with sarcoma receiving chemotherapy
Chemotherapy has improved the prognosis of patients with sarcomas. However, it may suppress anti‐tumor immunity. Recently, we reported a novel CD8(+) memory T cell population with a chemo‐resistance property, “young memory” T (T(YM)) cells. In this study, we investigated the proportion and function...
Autores principales: | Shibayama, Yuji, Tsukahara, Tomohide, Emori, Makoto, Murata, Kenji, Mizushima, Emi, Hirohashi, Yoshihiko, Kanaseki, Takayuki, Nakatsugawa, Munehide, Kubo, Terufumi, Yamashita, Toshihiko, Sato, Noriyuki, Torigoe, Toshihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581517/ https://www.ncbi.nlm.nih.gov/pubmed/28699227 http://dx.doi.org/10.1111/cas.13319 |
Ejemplares similares
-
Osteosarcoma‐initiating cells show high aerobic glycolysis and attenuation of oxidative phosphorylation mediated by LIN28B
por: Mizushima, Emi, et al.
Publicado: (2019) -
Identification of a novel human memory T-cell population with the characteristics of stem-like chemo-resistance
por: Murata, Kenji, et al.
Publicado: (2016) -
Development of a T‐cell receptor multimer with high avidity for detecting a naturally presented tumor‐associated antigen on osteosarcoma cells
por: Watanabe, Kazue, et al.
Publicado: (2018) -
Development of an artificial antibody specific for HLA/peptide complex derived from cancer stem-like cell/cancer-initiating cell antigen DNAJB8
por: Tadano, Hiroki, et al.
Publicado: (2020) -
Fundamental and Essential Knowledge for Pathologists Engaged in the Research and Practice of Immune Checkpoint Inhibitor-Based Cancer Immunotherapy
por: Kubo, Terufumi, et al.
Publicado: (2021)